Applicant, as named in the Orange Book

Acrotech Biopharma

Next listed expiry: Beleodaq on 27 Oct 2027. 4 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Beleodaq NDA 206256 belinostat	belinostat	27 Oct 2027 patent	patent
Evomela NDA 207155 melphalan hydrochloride	melphalan hydrochloride	30 Jan 2034 patent	patent
Adquey NDA 219474 difamilast	difamilast	31 Dec 2036 patent	patent
Khapzory NDA 211226 levoleucovorin	levoleucovorin	25 Mar 2039 patent	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (1)

Drug	Ingredient	Earliest generic entry	Basis
Folotyn NDA 022468 · 2 strengths pralatrexate	pralatrexate	open now no listed protection	no listed protection